Atlas Trials

A Study to Evaluate Injection Pain and Local Tolerability Following Subcutaneous (SC) Administration of TV-46046

Clinical trial NCT03700658 · COMPLETED

Trial details

NCT number
NCT03700658
Sponsor
Teva Branded Pharmaceutical Products R&D, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Contraception
Start date
2019-01-15
Primary completion
2020-10-02
Enrollment
27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.